Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
INDV
$39.01
+2.07%
INDV · Indivior Pharmaceuticals, Inc.
$39.01
+0.79 (+2.07%)
At close · Aug 14
Market Cap
$4.60B
Shares
118.01M
All earnings calls
Earnings call · FY2025 Q1
Indivior Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
Indivior Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$266.00M
-6.3% YoY
Diluted EPS
$0.38
-15.6% YoY
Gross margin
83.1%
-3.5 pp YoY
Net income
$47.00M
-23% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Apr 24, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed May 1, 2025 · complete as-filed document